Donated plasma is used to create more than two dozen life-saving medical therapies, from clotting treatments for hemophilia to immune therapies for people whose bodies can’t fight infections on their own. It’s also transfused directly into trauma and burn patients to help control bleeding and prevent shock. The demand is enormous: treating just one patient with a primary immune deficiency requires more than 130 plasma donations per year.
How Donated Plasma Becomes Medicine
Most donated plasma doesn’t go straight into another person’s veins. Instead, it’s sent to a manufacturing facility where it’s separated into its individual components through a process called fractionation. This breaks plasma down into specific proteins, each of which becomes a different pharmaceutical product. The FDA regulates more than 30 categories of these fractionated plasma products, including albumin, immune globulins, clotting factors, and targeted antibody treatments.
Think of plasma as raw material. A single donation contains hundreds of proteins, and fractionation sorts them out so each one can be concentrated, purified, and turned into a therapy tailored for a specific condition. That’s why plasma donation centers collect such large volumes and why repeat donations are so important to maintaining supply.
Immune Therapy for Vulnerable Patients
One of the largest uses of donated plasma is producing immune globulin, a concentrated dose of antibodies pooled from thousands of donors. People with primary immunodeficiency disorders are born with immune systems that produce few or no antibodies, leaving them dangerously susceptible to infections most people fight off without thinking. Regular infusions of immune globulin, given either intravenously or injected under the skin, essentially replace the immune protection their bodies can’t make.
These patients typically need infusions every few weeks for their entire lives. Because each dose draws from a large pool of donated plasma, keeping a single patient supplied takes a staggering amount of raw material. The American College of Allergy, Asthma & Immunology estimates it takes more than 130 individual plasma donations to treat one immunodeficiency patient for one year. Immune globulin therapy is also used for autoimmune conditions and certain neurological diseases like chronic inflammatory polyneuropathy and myasthenia gravis, where it helps calm an overactive immune system.
Clotting Factors for Bleeding Disorders
Plasma contains the proteins responsible for blood clotting, and people who lack specific clotting factors face life-threatening bleeding from even minor injuries. Hemophilia A and hemophilia B are the most well-known examples, but donated plasma also supplies treatments for von Willebrand disease and antithrombin III deficiency. Fractionation isolates these clotting proteins so they can be concentrated into therapies patients infuse at home or receive at treatment centers, often on a regular preventive schedule rather than only during bleeding episodes.
The FDA-regulated product list includes multiple types of antihemophilic factor, prothrombin complex concentrates, fibrinogen, and thrombin, each targeting a different step in the clotting process. For patients with these conditions, a reliable plasma supply is the difference between living a relatively normal life and facing repeated hospitalizations.
Emergency Trauma and Burn Care
In emergency rooms and operating rooms, plasma is transfused directly to help patients survive massive blood loss. Hemorrhage is the most common cause of death within the first hour of arrival at a trauma center, responsible for more than 80 percent of deaths in the operating room and nearly half of all deaths in the first 24 hours after injury. Plasma transfusion helps in two critical ways: it provides clotting proteins to stop bleeding and it restores blood volume to prevent the dangerous drop in blood pressure known as shock.
Current trauma guidelines call for transfusing plasma alongside red blood cells in a ratio between 1:1 and 1:2, meaning a patient receiving six units of red blood cells might also receive three to six units of plasma. Trauma centers that keep thawed plasma ready for immediate use have seen reductions in overall blood product use, because getting clotting support to the patient faster helps control bleeding sooner. Burn patients similarly receive plasma to replace the fluid and proteins lost through damaged skin.
Targeted Antibody Treatments
Some plasma-derived therapies use antibodies from donors who have specific immune protection. These are highly targeted products that treat conditions no other medication can address effectively.
- Tetanus immune globulin is made from the plasma of people who have been vaccinated against tetanus. Their antibodies can be given to someone with a tetanus infection as an immediate, lifesaving treatment.
- Rabies immune globulin works on the same principle, providing borrowed antibodies to people exposed to rabies before their own immune response kicks in.
- Rh immune globulin protects pregnancies where a mother’s blood type is Rh-negative but her baby’s is Rh-positive. Without treatment, the mother’s immune system can attack the baby’s blood cells, potentially causing brain damage or death. Plasma-derived antibodies prevent this immune reaction.
- Hepatitis B immune globulin provides immediate protection after exposure to the hepatitis B virus, often used for newborns of infected mothers.
Albumin for Critical Illness
Albumin is the most abundant protein in plasma, making up about 55 percent of all plasma proteins. Its primary job is maintaining fluid balance: albumin’s molecular size and electrical charge create the osmotic pressure that keeps fluid inside blood vessels rather than leaking into surrounding tissues. When albumin levels drop, as they do in severe burns, liver failure, or major surgery, fluid shifts out of the bloodstream and into tissues, causing dangerous swelling and a drop in blood pressure.
Purified albumin from donated plasma is used to restore this balance in critically ill patients. It also serves as a carrier protein, transporting hormones, medications, and other molecules through the bloodstream, and functions as an antioxidant that binds harmful free radicals. Albumin infusions are one of the most commonly used plasma-derived products in hospitals worldwide.
Rare and Genetic Conditions
Several lesser-known but serious conditions depend entirely on plasma-derived therapies. Alpha-1 antitrypsin deficiency is a genetic condition that leaves the lungs vulnerable to progressive damage. The missing protective protein is extracted from donated plasma and given as a regular infusion to slow lung deterioration. Hereditary angioedema, which causes sudden and potentially fatal swelling of the face, throat, or abdomen, is treated with C1 esterase inhibitor, another plasma-derived product. Kawasaki disease, an inflammatory condition that primarily affects children and can damage the heart, is treated with high-dose immune globulin.
For many of these conditions, no synthetic alternative exists. The treatments come from human plasma or they don’t exist at all, which is why donation centers emphasize the need for a consistent, high-volume supply.
How Quickly Your Body Recovers
If you’re considering donating, your body replaces plasma faster than any other blood component. With proper hydration, your blood volume returns to normal within 48 hours. This rapid regeneration is why plasma donors can give more frequently than whole blood donors, typically every 28 days or even more often at source plasma centers. The proteins in your plasma take a bit longer to fully replenish, but the overall recovery is quick enough that regular donation is safe for healthy adults.